Patrick Fortune - PAREXEL International Independent Director
Director
Dr. Patrick J. Fortune, Ph.D., is Independent Director of Parexel International Corporationrationration. is Chairman of the Human Resources Committee and a member of the Audit and Finance Committee and the Compensation Committee. Since September 2014, Dr. Fortune has served as Sector LeaderSenior Advisor, Innovation of Partners Healthcare. From June 2012 to September 2014, he served as Senior General Manager of Innovations at The Cleveland Clinic, an educational medical center. Since September 2001, Dr. Fortune has served as a Partner of Boston Millennia Partners, a VC firm. From September 2001 to June 2005, he served as Executive Chairman of Knowledge Impact Systems, Inc., a software end user training company. From April 1999 to June 2001, he served as President, Chief Operating Officer and a director of New Era of Networks, Inc., an Internet software and services company. From October 1995 to March 1999, Dr. Fortune was Vice President, Information Technology and Chief Information Officer of Monsanto Company, an agricultural, pharmaceutical and food products company. From August 1994 to July 1995, Dr. Fortune was President and Chief Operating Officer, Chief Information Officer and a member of the Board of Directors of Coram Healthcare Corporationrationration, a medical therapy services company. From December 1991 to August 1994, Dr. Fortune was Corporationrationrate Vice President, Information Management at BristolMyers Squibb, a pharmaceutical company. Prior to that, Dr. Fortune was Senior Vice President and General Manager of Packaging Corporation of America, a subsidiary of Tenneco, and held several management positions with Baxter International, Inc., including Corporationrationrate Vice President President, Parenteral Products Division Vice President, Research and Development and Vice President, Information Services. Dr. Fortune also served on the boards of directors of CombinatoRx, Incorporated from 2006 to 2009 and EPIX Pharmaceuticals, Inc. from 2006 to 2008. since 1996.
| Age | 68 |
| Tenure | 28 years |
| Phone | 781 487-9900 |
| Web | http://www.parexel.com |
PAREXEL International Management Efficiency
The company has return on total asset (ROA) of 0.0471 % which means that it generated a profit of $0.0471 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.15 %, meaning that it created $0.15 on every $100 dollars invested by stockholders. PAREXEL International's management efficiency ratios could be used to measure how well PAREXEL International manages its routine affairs as well as how well it operates its assets and liabilities.The company currently holds 671.5 M in liabilities with Debt to Equity (D/E) ratio of 105.8, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. PAREXEL International has a current ratio of 1.42, which is within standard range for the sector. Debt can assist PAREXEL International until it has trouble settling it off, either with new capital or with free cash flow. So, PAREXEL International's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like PAREXEL International sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for PAREXEL to invest in growth at high rates of return. When we think about PAREXEL International's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | DIRECTOR Age | ||
| John Hodgson | Analog Devices | 71 | |
| Kenton Sicchitano | Analog Devices | 73 | |
| Mark Little | Analog Devices | 65 | |
| Anantha Chandrakasan | Analog Devices | 49 | |
| Lothar Maier | FormFactor | 63 | |
| Michael Yates | Ainsworth Game Technology | 63 | |
| Kareem Sethi | Emerson Radio | 41 | |
| Bruce Evans | Analog Devices | 58 | |
| Peter Thomas | Boyd Gaming | 71 | |
| John Struble | BK Technologies | 41 | |
| Kin Yuen | Emerson Radio | 64 | |
| E Payne | BK Technologies | 68 | |
| Ali Husain | Analog Devices | N/A | |
| Gregory Hunt | Emerson Radio | 57 | |
| Lisa Su | Analog Devices | 48 | |
| Ryan Turner | BK Technologies | 39 | |
| James Champy | Analog Devices | 75 | |
| Gray Payne | BK Technologies | 70 | |
| John Bailey | Boyd Gaming | 60 | |
| Charles Lanktree | BK Technologies | 68 | |
| Graeme Campbell | Ainsworth Game Technology | 60 | |
Management Performance
| Return On Equity | 0.15 | |||
| Return On Asset | 0.0471 |
PAREXEL International Leadership Team
Elected by the shareholders, the PAREXEL International's board of directors comprises two types of representatives: PAREXEL International inside directors who are chosen from within the company, and outside directors, selected externally and held independent of PAREXEL. The board's role is to monitor PAREXEL International's management team and ensure that shareholders' interests are well served. PAREXEL International's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, PAREXEL International's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Michelle Graham, Chief Human Resource Officer, Senior Vice President | ||
| Ulf Schneider, Chief Administrative Officer, Senior Vice President | ||
| Thomas Senderovitz, Senior Vice President - Clinical Research Services | ||
| Dana Callow, Presiding Independent Director | ||
| Emma Reeve, Interim CFO, Corporate Vice President Controller | ||
| Josef Rickenbach, Founder, Chairman and CEO | ||
| Patrick Fortune, Independent Director | ||
| Eduard Holdener, Independent Director | ||
| Simon Harford, CFO, Senior Vice President | ||
| Joshua Schultz, Senior Vice President-Worldwide Head of PAREXEL Access | ||
| Gadi Saarony, Senior Vice President - Clinical Research Services | ||
| Ellen Zane, Director, Member of Compensation Committee, Member of HR Committee, CEO of Tufts Medical Center and President of Tufts Medical Center | ||
| Christian Dreger, Senior Vice President - Parexel Access and Parexel Consulting | ||
| Xavier Flinois, President - Perceptive Informatics | ||
| Douglas Batt, Sr. VP, General Counsel and Secretary | ||
| Sybrand Pretorius, Senior Vice President Chief Scientific Officer | ||
| Maykin Ho, Director | ||
| Richard Love, Independent Director | ||
| Ronald Aldridge, Sr. Director, Investor Relations | ||
| Mark Goldberg, President COO | ||
| Roland Andersson, Senior Vice President - Clinical Research Services | ||
| Christopher Lindop, Independent Director | ||
| Ingo Bank, CFO and Sr. VP | ||
| David Godwin, Senior Vice President-Global Business |
PAREXEL Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is PAREXEL International a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.15 | |||
| Return On Asset | 0.0471 | |||
| Profit Margin | 0.04 % | |||
| Operating Margin | 11.04 % | |||
| Current Valuation | 4.87 B | |||
| Shares Outstanding | 51.12 M | |||
| Shares Owned By Insiders | 2.00 % | |||
| Shares Owned By Institutions | 90.14 % | |||
| Number Of Shares Shorted | 506.64 K | |||
| Price To Earning | 42.76 X |
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as PAREXEL International using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Consideration for investing in PAREXEL Stock
If you are still planning to invest in PAREXEL International check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the PAREXEL International's history and understand the potential risks before investing.
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| CEOs Directory Screen CEOs from public companies around the world |